Market Overview

UPDATE: Albany Molecular Research Shares Down Roughly 20% At $10.27, Fell As Much As 23.3% At Low On Disclosure That Bristol-Myers Squibb Has Canceled Development of Drug With Company

Share:

Related Articles (AMRI + BMY)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→